Hemostatic Mechanisms and Metastasis: Developments in Oncology, cartea 22
Editat de Kenneth V. Honn, Bonnie F. Sloaneen Limba Engleză Hardback – 31 iul 1984
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1418.68 lei 6-8 săpt. | |
Springer Us – 13 oct 2011 | 1418.68 lei 6-8 săpt. | |
Hardback (1) | 1425.76 lei 6-8 săpt. | |
Springer Us – 31 iul 1984 | 1425.76 lei 6-8 săpt. |
Din seria Developments in Oncology
- 5% Preț: 360.70 lei
- 5% Preț: 384.80 lei
- 5% Preț: 345.71 lei
- 5% Preț: 1096.98 lei
- 5% Preț: 360.86 lei
- 5% Preț: 1125.88 lei
- 5% Preț: 3183.63 lei
- 5% Preț: 371.30 lei
- 5% Preț: 374.57 lei
- 5% Preț: 1417.91 lei
- 5% Preț: 375.34 lei
- 5% Preț: 368.57 lei
- 5% Preț: 1102.10 lei
- 5% Preț: 368.37 lei
- 15% Preț: 604.56 lei
- 5% Preț: 1119.10 lei
- 5% Preț: 374.57 lei
- 5% Preț: 1416.09 lei
- 5% Preț: 723.21 lei
- 5% Preț: 713.33 lei
- 5% Preț: 1424.16 lei
- 5% Preț: 718.65 lei
- 5% Preț: 367.64 lei
- 5% Preț: 1423.22 lei
- 5% Preț: 1097.71 lei
- 5% Preț: 3836.15 lei
- 5% Preț: 1100.64 lei
- 5% Preț: 1109.08 lei
- 5% Preț: 1419.39 lei
- 5% Preț: 1439.31 lei
- 5% Preț: 1114.71 lei
Preț: 1425.76 lei
Preț vechi: 1500.81 lei
-5% Nou
Puncte Express: 2139
Preț estimativ în valută:
272.84€ • 283.13$ • 228.06£
272.84€ • 283.13$ • 228.06£
Carte tipărită la comandă
Livrare economică 17-31 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780898386677
ISBN-10: 0898386675
Pagini: 432
Ilustrații: XXII, 432 p.
Dimensiuni: 155 x 235 x 25 mm
Greutate: 0.82 kg
Ediția:1984
Editura: Springer Us
Colecția Springer
Seria Developments in Oncology
Locul publicării:New York, NY, United States
ISBN-10: 0898386675
Pagini: 432
Ilustrații: XXII, 432 p.
Dimensiuni: 155 x 235 x 25 mm
Greutate: 0.82 kg
Ediția:1984
Editura: Springer Us
Colecția Springer
Seria Developments in Oncology
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
1. Is there Clinical Relevance for Therapies which Disrupt the Metastatic Cascade?.- 2. Overview of the Metastatic Cascade.- 3. Overview on Blood Coagulation Proteins.- 4. The Microinjury Hypothesis and Metastasis.- 5. Hemostatic Abnormalities in Tumor-Bearing Animals.- 6. Evidence for a Tumor Proteinase in Blood Coagulation.- 7. Relationship between Procoagulant Activity and Metastatic Capacity of Tumor Cells.- 8. Fibrin Formation: Implications for Tumor Growth and Metastasis.- 9. Perspectives on the Role of Platelets in Hemostasis and Thrombosis.- 10. Mechanisms of Platelet Aggregation by Murine Tumor Cell Spheroids.- 11. Heterogenous Mechanisms of Tumor Cell-Induced Platelet Aggregation with Possible Pharmacological Strategy Toward Prevention of Metastases.- 12. Tumor Cysteine Proteinases, Platelet Aggregation and Metastasis.- 13. Arachidonate Metabolism in Platelets and Blood Vessels.- 14. Prostacyclin/Thromboxanes and Tumor Cell Metastasis.- 15. Evidence for Altered Arachidonic Acid Metabolism in Tumor Metastasis.- 16. Calcium Channel Blockers: Inhibitors of Tumor Cell-Platelet-Endothelial Cell Interactions.- 17. Evidence for the Antimetastatic Effects of Coumarin Derivatives.- 18. Mitogenic Stimulation of Tumor Cells by Platelet Derived Growth Factors.- 19. Role of the Vascular Endothelium in Hemostasis.- 20. The Cellular Interactions of Metastatic Tumor Cells with Special Reference to Endothelial Cells and their Basal Lamina-Like Matrix.- 21. Interaction of Tumor Cells with the Basement Membrane of Endothelium.- 22. Hemostatic Alterations in Cancer Patients.- 23. Historical Overview of Clinical Experience with Anticoagulant Therapy.- 24. Rationale for Anticoagulant Treatment of Cancer.- 25. The Design and Execution of Anticoagulant Therapy Trials in Cancer.- 26.Experimental and Clinical Experience with Pyrimido — Pyrimidine Derivatives in the Inhibition of Malignant Metastasis Formation.- 27. Current Clinical Trials with Anticoagulant Therapy in the Management of Cancer Patients.